Does radiomics have added value in predicting the development of brain metastases in patients with radically treated stage III non-small cell lung cancer (NSCLC)?

Autor: Hendriks, L., Keek, S. A., Chatterjee, A., Belderbos, J., Bootsma, G., van den Borne, B., Dingemans, A-M. C., Gietema, H., Groen, H. J. M., Herder, G., Pitz, C., Praag, J., De Ruysscher, D., Schoenmaekers, J., Smit, H. J. M., Stigt, J., Westenend, M., Zeng, H., Woodruff, H., Lambin, P.
Přispěvatelé: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE)
Jazyk: angličtina
Rok vydání: 2022
Zdroj: Annals of Oncology, 33, S91-S91. Oxford University Press
ISSN: 0923-7534
Databáze: OpenAIRE